Cancel

iMedX Australia

(No Reviews)
110/12/14 Cato St, Hawthorn East VIC 3123, Australia

iMedX Australia is located in Boroondara City of Victoria state. On the street of Cato Street and street number is 14. To communicate or ask something with the place, the Phone number is 1300 727 423. You can get more information from their website.
The coordinates that you can use in navigation applications to get to find iMedX Australia quickly are -37.8435479 ,145.043264

Contact and Address

Address: 110/12/14 Cato St, Hawthorn East VIC 3123, Australia
Postal code: 3123
Phone: 1300 727 423
Website: http://ozescribe.com.au/

Opening Hours:

Monday:9:00 AM – 5:00 PM
Tuesday:9:00 AM – 5:00 PM
Wednesday:9:00 AM – 5:00 PM
Thursday:9:00 AM – 5:00 PM
Friday:9:00 AM – 5:00 PM
Saturday:Closed
Sunday:Closed

Location & routing

Get Directions

Reviews

There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about iMedX Australia, use the form below and your opinion, advice or comment will appear in this space.

Write a Review

Photos of iMedX Australia

iMedX Australia | 110/12/14 Cato St, Hawthorn East VIC 3123, Australia | Phone: 1300 727 423

iMedX Australia On the Web

Leader in Clinical Documentation & Transcription... - iMedX Australia

iMedX Australia provides a range of solutions across the Clinical Documentation space including Clinical Coding and Audit services, as well as Transcription, Documentation Improvement, Education and Billing services to Public and Private Hospitals.


IMedX Australia - Home | Facebook

IMedX Australia. Medical and health in Hawthorn East, Victoria. +61 1300 727 423. Contact IMedX Australia on Messenger.


imedx australia - Bing

iMedX Australia provides a range of solutions across the Clinical Documentation space including Clinical Coding and Audit services, as well as Transcription, Documentation Improvement In 2015 iMedX acquired OzeScribe Pty Ltd, Australia's leading Clinical Documentation service provider.


iMedX Australia Pty Mergers and Acquisitions Summary | Mergr

iMedX Australia Pty has acquired 1 company, including 1 in the last 5 years. The Company's most targeted sectors include business services (100%). Join Mergr and gain access to iMedX Australia Pty's M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in...


iMedX Australia (OzeScribe) are recruiting | Forum - WAHM.com

iMedX Australia (OzeScribe), an Australian-based and operated company owned by iMedX Inc., is a global leader in medical dictation and transcription services. As a leading integrated medical document management and health information...


iMedX Australia Answers all of Your Medical Transcription Questions

With iMedX Australia you start out as an Intern, where you are paid to be trained. This process generally lasts around two weeks and then you iMedX Australia has MT/HDSs in North America and Australia, so in short: no. All of our teams have Skype groups to contact each other with and answer...


iMedx Australia Instructional Vdeo_Module 01 - YouTube

The Science of Humanology - Продолжительность: 2:24 iMedX Recommended for you.


Brett from iMedX Australia Stopped by to Answer all of Your Medical...

The post Brett from iMedX Australia Stopped by to Answer all of Your Medical Transcription Questions appeared first on CanScribe Career College.


"Ozescribe.com.au" Keyword Found Websites Listing | Keyword...

iMedX Australia Corporate Headquarters. 1300-727-423 · [email protected]. Imedx.com. As Australia and New Zealand's leading medical transcription organisation, our competitive outsourced model assists your organisation by achieving bottom-line documentation cost savings associated with...


Medicaltranscription.emdat.com | Linked At Least 10 Domains

Client Login - iMedX Australia. (7 days ago) Need assistance? simply download the below remote assistance applications (for mac or pc) and contact our support line on 1300 727 423. 1300 305 998 emdat has been re-named to escription one. please note: the emdat platform has undergone a.